AB Science publishes study showing masitinib survival benefits in ALS patients
Go back to AB Science publishes study showing masitinib survival benefits in ALS patients| ALLIANCEBERNSTEIN HOLDING, L.P. (NYSE: AB) | Delayed: 36.06 +0.11 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.95 | 52 Week High | $26.24 | |||
| Open | $36.15 | 52 Week Low | $16.11 | |||
| Day High | $36.25 | P/E | 21.21 | |||
| Day Low | $35.90 | EPS | $1.70 | |||
| Volume | 165,758 | |||||
